• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    The Vita Coco Company Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    3/26/25 4:04:09 PM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $COCO alert in real time by email
    coco-20250326
    0001482981FALSE00014829812025-02-262025-02-26

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _____________________________
    FORM 8-K
    _____________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of report (Date of earliest event reported): March 26, 2025
    _____________________________
    The Vita Coco Company, Inc.
    (Exact name of registrant as specified in its charter)
    _____________________________
    Delaware
    001-40950
    11-3713156
    (State or other jurisdiction of
    incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)
    250 Park Avenue South
    Seventh Floor
    New York, New York 10003
    (Address of principal executive offices) (Zip Code)
    (Registrant’s telephone number, include area code) (212) 206-0763
    N/A
    (Former Name or Former Address, if Changed Since Last Report)
    _____________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class

    Trading
    Symbols

    Name of each exchange
    on which registered
    Common Stock, $0.01 par value per share

    COCO

    The Nasdaq Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 7.01    Regulation FD Disclosure.

    On March 26, 2025, The Vita Coco Company, Inc. (the “Company”) issued a press release responding to a short seller report issued on March 26, 2025 by NINGI Research, a short seller of Company common stock. A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

    The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
    Item 9.01    Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit No.
    Description
    99.1
    Press release, dated March 26, 2025
    104
    Cover Page Interactive Data File (embedded with Inline XBRL document)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    THE VITA COCO COMPANY, INC.



    Date: March 26, 2025
    By:
    /s/ Corey Baker


    Name: Corey Baker


    Title: Chief Financial Officer

    Get the next $COCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $COCO

    DatePrice TargetRatingAnalyst
    1/27/2025$36.00Overweight → Equal-Weight
    Stephens
    7/24/2024$35.00 → $31.00Buy
    Jefferies
    7/12/2024$29.00 → $28.00Overweight → Neutral
    Piper Sandler
    2/29/2024$31.00Equal-Weight → Overweight
    Stephens
    1/22/2024Outperform → Mkt Perform
    William Blair
    11/13/2023$33.00Buy
    Jefferies
    9/19/2023$29.00Equal-Weight
    Morgan Stanley
    8/2/2023Buy → Neutral
    BofA Securities
    More analyst ratings